Sirt1 activation by either resveratrol or Sirt1 agonist (SRT3025) decreases unilateral ureteral obstruction (UUO), 5/6 nephrectomy-induced renal inflammation, and ECM accumulation by Smad3 acetylation [15,16]. Here, SIRT1 is linked to Ureteral obstruction.